EML1
geneOn this page
Also known as EMAPHuEMAPELP79
Summary
EML1 (EMAP like 1, HGNC:3330) is a protein-coding gene on chromosome 14q32.2, encoding Echinoderm microtubule-associated protein-like 1 (O00423). Modulates the assembly and organization of the microtubule cytoskeleton, and probably plays a role in regulating the orientation of the mitotic spindle and the orientation of the plane of cell division.
Human echinoderm microtubule-associated protein-like is a strong candidate for the Usher syndrome type 1A gene. Usher syndromes (USHs) are a group of genetic disorders consisting of congenital deafness, retinitis pigmentosa, and vestibular dysfunction of variable onset and severity depending on the genetic type. The disease process in USHs involves the entire brain and is not limited to the posterior fossa or auditory and visual systems. The USHs are catagorized as type I (USH1A, USH1B, USH1C, USH1D, USH1E and USH1F), type II (USH2A and USH2B) and type III (USH3). The type I is the most severe form. Gene loci responsible for these three types are all mapped. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 2009 — RefSeq curated summary.
At a glance
- Gene–disease (curated): band heterotopia of brain (Definitive, ClinGen) — +1 more curated relationship
- GWAS associations: 9
- Clinical variants (ClinVar): 254 total — 8 pathogenic, 3 likely-pathogenic
- Phenotypes (HPO): 19
- MANE Select transcript:
NM_004434
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3330 |
| Approved symbol | EML1 |
| Name | EMAP like 1 |
| Location | 14q32.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | EMAP, HuEMAP, ELP79 |
| Ensembl gene | ENSG00000066629 |
| Ensembl biotype | protein_coding |
| OMIM | 602033 |
| Entrez | 2009 |
Gene structure
Transcript identifiers
Ensembl transcripts: 30 — 22 protein_coding, 3 retained_intron, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined
ENST00000262233, ENST00000327921, ENST00000334192, ENST00000553313, ENST00000553720, ENST00000554111, ENST00000554386, ENST00000554479, ENST00000554553, ENST00000555096, ENST00000555145, ENST00000555277, ENST00000555812, ENST00000556199, ENST00000556714, ENST00000556758, ENST00000556835, ENST00000556947, ENST00000557313, ENST00000557741, ENST00000649352, ENST00000697131, ENST00000909078, ENST00000909079, ENST00000909080, ENST00000909081, ENST00000909082, ENST00000912116, ENST00000940979, ENST00000940980
RefSeq mRNA: 4 — MANE Select: NM_004434
NM_001008707, NM_001375411, NM_001375412, NM_004434
CCDS: CCDS32154, CCDS32155
Canonical transcript exons
ENST00000262233 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000941475 | 99894629 | 99894758 |
| ENSE00000941483 | 99914566 | 99914697 |
| ENSE00000941484 | 99917782 | 99917849 |
| ENSE00000996488 | 99891199 | 99891227 |
| ENSE00001363583 | 99939987 | 99942060 |
| ENSE00003477678 | 99850853 | 99851035 |
| ENSE00003495008 | 99897145 | 99897294 |
| ENSE00003516992 | 99898233 | 99898302 |
| ENSE00003527445 | 99920789 | 99920877 |
| ENSE00003542521 | 99865514 | 99865646 |
| ENSE00003552650 | 99939197 | 99939327 |
| ENSE00003567470 | 99878485 | 99878619 |
| ENSE00003586412 | 99936029 | 99936126 |
| ENSE00003621546 | 99910242 | 99910341 |
| ENSE00003621758 | 99937817 | 99937912 |
| ENSE00003638434 | 99936247 | 99936334 |
| ENSE00003638764 | 99907638 | 99907733 |
| ENSE00003639118 | 99914179 | 99914304 |
| ENSE00003673485 | 99911422 | 99911576 |
| ENSE00003685072 | 99909345 | 99909479 |
| ENSE00003686835 | 99900929 | 99901039 |
| ENSE00003900021 | 99793413 | 99793543 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 98.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.8567 / max 217.5538, expressed in 1410 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 141404 | 5.8963 | 1306 |
| 141403 | 2.3646 | 1063 |
| 141398 | 1.3523 | 466 |
| 141402 | 0.7214 | 445 |
| 141401 | 0.2644 | 115 |
| 141400 | 0.1798 | 52 |
| 141399 | 0.0780 | 43 |
Top tissues by expression
296 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 98.51 | gold quality |
| ganglionic eminence | UBERON:0004023 | 95.60 | gold quality |
| mucosa of stomach | UBERON:0001199 | 94.67 | gold quality |
| synovial joint | UBERON:0002217 | 94.29 | gold quality |
| colonic epithelium | UBERON:0000397 | 93.00 | gold quality |
| ventricular zone | UBERON:0003053 | 92.53 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 92.25 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.77 | gold quality |
| calcaneal tendon | UBERON:0003701 | 91.75 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 91.50 | gold quality |
| lower esophagus | UBERON:0013473 | 91.45 | gold quality |
| endometrium epithelium | UBERON:0004811 | 90.76 | gold quality |
| tendon | UBERON:0000043 | 90.50 | gold quality |
| right lung | UBERON:0002167 | 90.46 | gold quality |
| amniotic fluid | UBERON:0000173 | 90.38 | gold quality |
| stromal cell of endometrium | CL:0002255 | 90.26 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 90.08 | gold quality |
| sural nerve | UBERON:0015488 | 89.59 | gold quality |
| gall bladder | UBERON:0002110 | 89.05 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 88.45 | gold quality |
| frontal pole | UBERON:0002795 | 88.43 | gold quality |
| bronchial epithelial cell | CL:0002328 | 88.10 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 87.84 | gold quality |
| corpus callosum | UBERON:0002336 | 87.67 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 87.20 | gold quality |
| right coronary artery | UBERON:0001625 | 86.77 | gold quality |
| caudate nucleus | UBERON:0001873 | 86.68 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 86.59 | gold quality |
| retina | UBERON:0000966 | 86.58 | gold quality |
| apex of heart | UBERON:0002098 | 86.52 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 29.20 |
| E-ANND-3 | yes | 10.10 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
115 targeting EML1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
Literature-anchored findings (GeneRIF, showing 8)
- determined a 2.6-A crystal structure of the representative approximately 70-kDa core of EML1, revealing an intimately associated pair of beta-propellers, which we term a TAPE (tandem atypical propeller in EMLs) domain (PMID:24706829)
- We found EML1 to be mutated in ribbon-like heterotopia in humans (PMID:24859200)
- We show that the trimerization domain (TD) of EML1 is necessary and sufficient for self-association. The TD is also essential for MT binding; however, this property requires an adjacent basic region. (PMID:25740311)
- a homozygous truncating variant in EML1 is a novel cause of congenital hydrocephalus. (PMID:28556411)
- Mutations in the Heterotopia Gene Eml1/EML1 Severely Disrupt the Formation of Primary Cilia. (PMID:31390572)
- biallelic EML1 disease-causing variants cause a highly specific pattern of congenital brain malformations, severe developmental delay, seizures and visual impairment (PMID:31710781)
- A novel missense variant in the EML1 gene associated with bilateral ribbon-like subcortical heterotopia leads to ciliary defects. (PMID:34211111)
- Human cerebral organoids reveal progenitor pathology in EML1-linked cortical malformation. (PMID:35289477)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | eml1 | ENSDARG00000042840 |
| mus_musculus | Eml1 | ENSMUSG00000058070 |
| rattus_norvegicus | Eml1 | ENSRNOG00000043143 |
Paralogs (9): EML2 (ENSG00000125746), EML4 (ENSG00000143924), EML3 (ENSG00000149499), CFAP251 (ENSG00000158023), WDR90 (ENSG00000161996), EML5 (ENSG00000165521), CFAP52 (ENSG00000166596), CFAP44 (ENSG00000206530), EML6 (ENSG00000214595)
Protein
Protein identifiers
Echinoderm microtubule-associated protein-like 1 — O00423 (reviewed: O00423)
All UniProt accessions (16): O00423, A0A3B3IU69, A0A8V8TKR4, F8W717, G3V3J1, G3V3N9, G3V497, G3V4H6, G3V4U5, G3V500, G3V538, G3V5C8, H0YJD8, H0YJK4, H0YJS9, H0YJY3
UniProt curated annotations — full annotation on UniProt →
Function. Modulates the assembly and organization of the microtubule cytoskeleton, and probably plays a role in regulating the orientation of the mitotic spindle and the orientation of the plane of cell division. Required for normal proliferation of neuronal progenitor cells in the developing brain and for normal brain development. Does not affect neuron migration per se.
Subunit / interactions. Homotrimer; self-association is mediated by the N-terminal coiled coil. Does not interact with EML3. Binds repolymerizing microtubules. Binds unpolymerized tubulins via its WD repeat region. Interacts with TASOR.
Subcellular location. Cytoplasm. Perinuclear region. Cytoskeleton.
Tissue specificity. Ubiquitous; expressed in most tissues with the exception of thymus and peripheral blood lymphocytes.
Disease relevance. Band heterotopia (BH) [MIM:600348] A brain malformation of the lissencephaly spectrum, resulting from disordered neuronal migration and characterized by bands of gray matter interposed in the central white matter. Disease features include severe developmental delay with intellectual disability, enlarged head circumference, periventricular and ribbon-like subcortical heterotopia, polymicrogyria and agenesis of the corpus callosum. The disease is caused by variants affecting the gene represented in this entry.
Domain organisation. Contains a tandem atypical propeller in EMLs (TAPE) domain. The N-terminal beta-propeller is formed by canonical WD repeats; in contrast, the second beta-propeller contains one blade that is formed by discontinuous parts of the polypeptide chain. The N-terminal coiled coil is required for association with microtubules.
Similarity. Belongs to the WD repeat EMAP family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O00423-1 | 1 | yes |
| O00423-3 | 3 |
RefSeq proteins (4): NP_001008707, NP_001362340, NP_001362341, NP_004425* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR005108 | HELP | Conserved_site |
| IPR011047 | Quinoprotein_ADH-like_sf | Homologous_superfamily |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR050630 | WD_repeat_EMAP | Family |
| IPR055439 | Beta-prop_EML_1st | Domain |
| IPR055442 | Beta-prop_EML-like_2nd | Domain |
Pfam: PF03451, PF23409, PF23414
UniProt features (115 total): strand 58, repeat 12, turn 10, mutagenesis site 8, sequence conflict 7, sequence variant 6, helix 4, compositionally biased region 4, region of interest 2, chain 1, coiled-coil region 1, modified residue 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4CI8 | X-RAY DIFFRACTION | 2.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O00423-F1 | 86.49 | 0.76 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 113
Mutagenesis-validated functional residues (8):
| Position | Phenotype |
|---|---|
| 59–61 | no effect on tubulin binding. does not disrupt self-association. decreased association with microtubules. |
| 192 | abolishes tubulin binding; when associated with s-194; a-547; t-626; s-627; a-646 and a-786. |
| 194 | abolishes tubulin binding; when associated with s-192; a-547; t-626; s-627; a-646 and a-786. |
| 547 | abolishes tubulin binding; when associated with s-192; s-194; t-626; s-627; a-646 and a-786. |
| 626 | abolishes tubulin binding; when associated with s-192; s-194; a-547; s-627; a-646 and a-786. |
| 627 | abolishes tubulin binding; when associated with s-192; s-194; a-547; t-626; a-646 and a-786. |
| 646 | abolishes tubulin binding; when associated with s-192; s-194; a-547; t-626; s-627 and a-786. |
| 786 | abolishes tubulin binding; when associated with s-192; s-194; a-547; t-626; s-627 and a-646. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 190 (showing top):
GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION, GOBP_NEUROGENESIS, FOXO1_01, GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION, PAX8_B, MYOD_01, DELYS_THYROID_CANCER_DN, MODULE_99, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, ONDER_CDH1_TARGETS_2_UP, GOBP_MITOTIC_CELL_CYCLE, HTF_01, HIF1_Q3, GOBP_HEAD_DEVELOPMENT, RFX1_02
GO Biological Process (5): microtubule cytoskeleton organization (GO:0000226), hematopoietic progenitor cell differentiation (GO:0002244), mitotic spindle organization (GO:0007052), neuroblast proliferation (GO:0007405), brain development (GO:0007420)
GO Molecular Function (4): calcium ion binding (GO:0005509), microtubule binding (GO:0008017), tubulin binding (GO:0015631), protein binding (GO:0005515)
GO Cellular Component (10): cytosol (GO:0005829), microtubule (GO:0005874), microtubule associated complex (GO:0005875), perinuclear region of cytoplasm (GO:0048471), mitotic spindle pole (GO:0097431), mitotic spindle midzone (GO:1990023), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), microtubule cytoskeleton (GO:0015630), mitotic spindle (GO:0072686)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 2 |
| microtubule cytoskeleton | 2 |
| mitotic spindle | 2 |
| cytoskeleton organization | 1 |
| microtubule-based process | 1 |
| hemopoiesis | 1 |
| cell differentiation | 1 |
| mitotic cell cycle | 1 |
| spindle organization | 1 |
| microtubule cytoskeleton organization involved in mitosis | 1 |
| generation of neurons | 1 |
| neural precursor cell proliferation | 1 |
| central nervous system development | 1 |
| animal organ development | 1 |
| head development | 1 |
| metal ion binding | 1 |
| tubulin binding | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| polymeric cytoskeletal fiber | 1 |
| protein-containing complex | 1 |
| spindle pole | 1 |
| spindle midzone | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| cytoskeleton | 1 |
| spindle | 1 |
Protein interactions and networks
STRING
1873 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EML1 | ALK | Q9UM73 | 739 |
| EML1 | NUP214 | P35658 | 545 |
| EML1 | KIF2A | O00139 | 492 |
| EML1 | EGFR | P00533 | 471 |
| EML1 | TMEM91 | Q6ZNR0 | 453 |
| EML1 | OR52E2 | Q8NGJ4 | 450 |
| EML1 | ANKRD13B | Q86YJ7 | 450 |
| EML1 | KIAA0513 | O60268 | 449 |
| EML1 | ERMARD | Q5T6L9 | 448 |
| EML1 | RCSD1 | Q6JBY9 | 447 |
| EML1 | TMEM25 | Q86YD3 | 440 |
| EML1 | ETV6 | P41212 | 404 |
| EML1 | KIF13A | Q9H1H9 | 398 |
| EML1 | KIF5A | Q12840 | 398 |
| EML1 | ARFGEF2 | Q9Y6D5 | 396 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EML1 | ISG20L2 | psi-mi:“MI:0915”(physical association) | 0.620 |
| EML1 | CASP6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EML1 | LAMP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EML1 | STIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUDC | EML1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KXD1 | HIP1 | psi-mi:“MI:0914”(association) | 0.530 |
| EML1 | FXR1 | psi-mi:“MI:0915”(physical association) | 0.510 |
| EML1 | PTEN | psi-mi:“MI:0915”(physical association) | 0.370 |
| EML1 | UBE3A | psi-mi:“MI:0915”(physical association) | 0.370 |
| EML1 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | EML1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| DCUN1D1 | RGSL1 | psi-mi:“MI:0914”(association) | 0.350 |
| TUBB3 | TUBB8B | psi-mi:“MI:0914”(association) | 0.350 |
| EML1 | TUBB | psi-mi:“MI:0914”(association) | 0.350 |
| TUBB2B | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| FBXO28 | EML1 | psi-mi:“MI:0914”(association) | 0.350 |
| EML1 | EML2 | psi-mi:“MI:0914”(association) | 0.350 |
| VCP | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (51): EML1 (Affinity Capture-MS), EML1 (Affinity Capture-MS), ISG20L2 (Two-hybrid), EML1 (Proximity Label-MS), EML1 (Affinity Capture-MS), EML1 (Affinity Capture-Western), TUBA1A (Reconstituted Complex), TUBB3 (Reconstituted Complex), FBXO28 (Affinity Capture-MS), TUBB2A (Affinity Capture-MS), EML4 (Affinity Capture-MS), TUBB2B (Affinity Capture-MS), EML1 (Affinity Capture-MS), TUBB (Affinity Capture-MS), EML1 (Proximity Label-MS)
ESM2 similar proteins: A0A396ISC0, O00423, O13286, O17468, O61585, O94423, P26309, P38328, P43254, P53197, P78972, P93471, Q04199, Q05BC3, Q09373, Q12834, Q16MY0, Q2TAF3, Q32SG6, Q3E906, Q4PSE4, Q4V7Y7, Q4V8C3, Q54MZ3, Q5H7C0, Q5ZIU8, Q62623, Q652L2, Q6DIP5, Q6NVM2, Q6S7B0, Q7K0L4, Q7ZUV2, Q7ZVL2, Q7ZX22, Q86Y33, Q8BG40, Q8CFJ9, Q8L3Z8, Q8LPL5
Diamond homologs: O00423, O95834, Q05BC3, Q05BV3, Q26613, Q2TAF3, Q32P44, Q3UMY5, Q4V8C3, Q5SQM0, Q6DIP5, Q6ED65, Q6P6T4, Q6ZMW3, Q7TNG5, Q8BQM8, Q8VC03, Q9HC35, Q9N9X3, Q9VUI3, Q9Y1C1, B3MC74, B4JW81, B4KTK4, B4LJT7, B4MY77, P29829, Q9NFZ1, B6K1G6, O48847, Q15542, Q8C092, O22212, O45487, O75083, O88342, O93277, Q2KJH4, Q5RKI0, Q86HX1
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 26 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Selective autophagy | 5 | 66.3× | 5e-07 |
| Aggrephagy | 5 | 59.1× | 7e-07 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | 6 | 55.3× | 1e-07 |
| Recycling pathway of L1 | 5 | 53.3× | 1e-06 |
| COPI-independent Golgi-to-ER retrograde traffic | 5 | 49.4× | 1e-06 |
| Kinesins | 5 | 42.5× | 1e-06 |
| Autophagy | 6 | 42.4× | 3e-07 |
| Golgi-to-ER retrograde transport | 5 | 31.6× | 4e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| microtubule cytoskeleton organization | 6 | 30.3× | 1e-05 |
| mitotic cell cycle | 5 | 27.9× | 1e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
254 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 8 |
| Likely pathogenic | 3 |
| Uncertain significance | 106 |
| Likely benign | 74 |
| Benign | 52 |
Top pathogenic / likely-pathogenic (11)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1031421 | NM_004434.3(EML1):c.1820+1G>C | Pathogenic |
| 2133786 | NM_004434.3(EML1):c.1715_1735delinsAGAC (p.Ala572fs) | Pathogenic |
| 254258 | NM_004434.3(EML1):c.412C>T (p.Arg138Ter) | Pathogenic |
| 254260 | NM_004434.3(EML1):c.673T>C (p.Trp225Arg) | Pathogenic |
| 2754922 | NM_004434.3(EML1):c.753_765del (p.Ser252fs) | Pathogenic |
| 4796662 | NM_004434.3(EML1):c.547+1G>T | Pathogenic |
| 548146 | NM_004434.3(EML1):c.1567C>T (p.Arg523Ter) | Pathogenic |
| 813332 | GRCh37/hg19 14q32.2(chr14:100317190-101012999) | Pathogenic |
| 1028240 | NM_004434.3(EML1):c.1897C>T (p.Arg633Ter) | Likely pathogenic |
| 1710368 | NM_004434.3(EML1):c.136C>T (p.Gln46Ter) | Likely pathogenic |
| 254259 | NM_004434.3(EML1):c.727A>G (p.Thr243Ala) | Likely pathogenic |
SpliceAI
4275 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:99793505:GCCT:G | donor_gain | 1.0000 |
| 14:99850845:T:TA | acceptor_gain | 1.0000 |
| 14:99850850:TAG:T | acceptor_gain | 1.0000 |
| 14:99850851:A:AG | acceptor_gain | 1.0000 |
| 14:99850851:AG:A | acceptor_loss | 1.0000 |
| 14:99850851:AGA:A | acceptor_gain | 1.0000 |
| 14:99850852:G:GT | acceptor_gain | 1.0000 |
| 14:99850852:GAT:G | acceptor_gain | 1.0000 |
| 14:99851019:G:GT | donor_gain | 1.0000 |
| 14:99851020:A:T | donor_gain | 1.0000 |
| 14:99851031:CAAAG:C | donor_loss | 1.0000 |
| 14:99851032:AAAG:A | donor_loss | 1.0000 |
| 14:99851033:AAGG:A | donor_loss | 1.0000 |
| 14:99851036:GT:G | donor_loss | 1.0000 |
| 14:99851037:T:A | donor_loss | 1.0000 |
| 14:99865508:TTACA:T | acceptor_loss | 1.0000 |
| 14:99865510:ACAG:A | acceptor_loss | 1.0000 |
| 14:99865511:CAG:C | acceptor_loss | 1.0000 |
| 14:99865512:A:AG | acceptor_gain | 1.0000 |
| 14:99865513:G:A | acceptor_loss | 1.0000 |
| 14:99865513:G:GA | acceptor_gain | 1.0000 |
| 14:99865513:GC:G | acceptor_gain | 1.0000 |
| 14:99865513:GCA:G | acceptor_gain | 1.0000 |
| 14:99865513:GCAA:G | acceptor_gain | 1.0000 |
| 14:99865642:AAAAG:A | donor_loss | 1.0000 |
| 14:99865644:AAGG:A | donor_loss | 1.0000 |
| 14:99865645:AGG:A | donor_loss | 1.0000 |
| 14:99865646:GGT:G | donor_loss | 1.0000 |
| 14:99865647:G:GA | donor_loss | 1.0000 |
| 14:99865648:T:A | donor_loss | 1.0000 |
AlphaMissense
5338 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:99850949:T:C | L55P | 1.000 |
| 14:99850961:T:C | L59P | 1.000 |
| 14:99900953:T:A | W308R | 1.000 |
| 14:99900953:T:C | W308R | 1.000 |
| 14:99909412:G:A | G391E | 1.000 |
| 14:99909432:T:A | W398R | 1.000 |
| 14:99909432:T:C | W398R | 1.000 |
| 14:99910332:T:A | W444R | 1.000 |
| 14:99910332:T:C | W444R | 1.000 |
| 14:99920790:T:A | W608R | 1.000 |
| 14:99920790:T:C | W608R | 1.000 |
| 14:99936050:G:A | G644D | 1.000 |
| 14:99936256:A:C | S673R | 1.000 |
| 14:99936257:G:T | S673I | 1.000 |
| 14:99936258:C:A | S673R | 1.000 |
| 14:99936258:C:G | S673R | 1.000 |
| 14:99936259:T:C | F674L | 1.000 |
| 14:99936261:C:A | F674L | 1.000 |
| 14:99936261:C:G | F674L | 1.000 |
| 14:99936277:T:A | W680R | 1.000 |
| 14:99936277:T:C | W680R | 1.000 |
| 14:99936304:T:C | S689P | 1.000 |
| 14:99936310:T:C | S691P | 1.000 |
| 14:99936311:C:T | S691F | 1.000 |
| 14:99939281:A:C | D759A | 1.000 |
| 14:99939281:A:T | D759V | 1.000 |
| 14:99940024:T:A | V787D | 1.000 |
| 14:99940098:T:A | W812R | 1.000 |
| 14:99940098:T:C | W812R | 1.000 |
| 14:99850907:T:C | L41P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000008963 (14:99813975 G>A), RS1000027117 (14:99809326 G>T), RS1000057326 (14:99740719 G>A), RS1000059448 (14:99822555 G>A,T), RS1000076282 (14:99767646 G>A), RS1000139251 (14:99800190 A>G), RS1000143595 (14:99864129 A>G,T), RS1000154140 (14:99908102 G>A), RS1000164980 (14:99768981 G>C,T), RS1000171760 (14:99860543 C>G,T), RS1000195676 (14:99744228 C>T), RS1000209788 (14:99738464 C>A), RS1000238200 (14:99887862 C>G), RS1000238933 (14:99910899 C>A,T), RS1000255581 (14:99799959 A>G)
Disease associations
OMIM: gene MIM:602033 | disease phenotypes: MIM:600348, MIM:617557
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| band heterotopia of brain | Strong | Autosomal recessive |
| subcortical band heterotopia | Supportive | Autosomal recessive |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| band heterotopia of brain | Definitive | AR |
Mondo (3): band heterotopia of brain (MONDO:0010873), Gabriele de Vries syndrome (MONDO:0044738), subcortical band heterotopia (MONDO:0020491)
Orphanet (1): Gabriele-de Vries syndrome (Orphanet:506358)
HPO phenotypes
19 total (19 of 19 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000238 | Hydrocephalus |
| HP:0000256 | Macrocephaly |
| HP:0000708 | Atypical behavior |
| HP:0001250 | Seizure |
| HP:0001257 | Spasticity |
| HP:0001263 | Global developmental delay |
| HP:0001274 | Agenesis of corpus callosum |
| HP:0001357 | Plagiocephaly |
| HP:0002119 | Ventriculomegaly |
| HP:0002126 | Polymicrogyria |
| HP:0002282 | Gray matter heterotopia |
| HP:0002360 | Sleep disturbance |
| HP:0003577 | Congenital onset |
| HP:0006956 | Lateral ventricle dilatation |
| HP:0010864 | Severe intellectual disability |
| HP:0012736 | Profound global developmental delay |
| HP:0025517 | Hypoplastic hippocampus |
| HP:0032409 | Subcortical band heterotopia |
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003474_8 | Scalp hair shape | 1.000000e-07 |
| GCST005194_177 | Coronary artery disease | 4.000000e-08 |
| GCST006427_27 | Depression in smokers | 1.000000e-06 |
| GCST007096_151 | Pulse pressure | 7.000000e-10 |
| GCST007097_162 | Pulse pressure | 2.000000e-06 |
| GCST007097_163 | Pulse pressure | 3.000000e-08 |
| GCST008473_1 | Visceral fat | 3.000000e-06 |
| GCST010703_106 | Brain morphology (MOSTest) | 1.000000e-20 |
| GCST90000025_550 | Appendicular lean mass | 2.000000e-12 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004980 | appendicular lean mass |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C563950 | Band Heterotopia of Brain (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
45 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 4 |
| Air Pollutants | affects cotreatment, decreases expression, increases abundance, increases expression | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| methacrylaldehyde | decreases expression, increases abundance, affects cotreatment | 2 |
| Acrolein | increases abundance, affects cotreatment, decreases expression | 2 |
| Ozone | affects cotreatment, decreases expression, increases abundance | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Aflatoxin B1 | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| 2,4,6-tribromophenol | increases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| alpha-pinene | increases abundance, affects cotreatment, decreases expression | 1 |
| bisphenol A | affects cotreatment, affects methylation, decreases methylation | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| cobaltous chloride | decreases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| nickel sulfate | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| pentabrominated diphenyl ether 100 | increases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | affects cotreatment, affects methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_ZD03 | Mel 04.01 | Cancer cell line | Male |
| CVCL_ZD06 | Mel 12.07 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: band heterotopia of brain, subcortical band heterotopia
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): band heterotopia of brain, Gabriele de Vries syndrome, subcortical band heterotopia